| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |